Inhibition of Seminal emission is the main cause of anejaculation induced by a new highly selective alpha1A-blocker in normal volunteers

The Journal of Sexual Medicine
K KobayashiT Tsukamoto

Abstract

Recent studies have highlighted the influence of alpha1-adrenoceptor antagonists on ejaculatory function. We evaluated the effect of a new, highly selective alpha1A-blocker, silodosin, on ejaculatory function of normal volunteers. The study included 15 healthy male urologists who voluntarily participated in the study. They took 4 mg of silodosin or a placebo twice daily for 3 days in a randomized, double-blind crossover design. We investigated the ejaculatory volume, sperm count in urine after ejaculation, and fructose concentration in seminal plasma before and after administration of the agents. All volunteers on silodosin had a complete lack of ejaculation. Three days after completion of silodosin, the mean ejaculatory volume recovered to the baseline level. There was no sperm in urine after ejaculation under silodosin administration in any volunteer. All volunteers on silodosin had anejaculation and did not show post-ejaculate sperm in their urine. The mechanism of ejaculatory dysfunction caused by silodosin is a loss of seminal emission.

References

May 1, 1984·Journal of Reproduction and Fertility·N B OldereidK Purvis
Jul 11, 2003·The Journal of Urology·UNKNOWN AUA Practice Guidelines Committee
Nov 25, 2003·BJU International·K-E Andersson, M G Wyllie
Jan 21, 2006·The Journal of Sexual Medicine·Rany ShamloulHany Mokhtar
Mar 7, 2006·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Yasuhito MatsubaraIan Midgley
Mar 7, 2006·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Shin-ichi MutoNobuo Shibata
Aug 31, 2006·The Journal of Sexual Medicine·Gregory A Broderick
Aug 31, 2006·The Journal of Sexual Medicine·Gregory A Broderick
Aug 31, 2006·The Journal of Sexual Medicine·Craig F Donatucci
Aug 31, 2006·The Journal of Sexual Medicine·Ira D Sharlip
Aug 31, 2006·The Journal of Sexual Medicine·Ridwan Shabsigh
Aug 31, 2006·The Journal of Sexual Medicine·Wayne J G Hellstrom
Sep 6, 2006·The Journal of Urology·Wayne J G Hellstrom, Suresh C Sikka
Oct 3, 2006·International Journal of Urology : Official Journal of the Japanese Urological Association·Shin-ichi HisasueTaiji Tsukamoto
Apr 25, 2007·The Journal of Sexual Medicine·Hossein Sadeghi-Nejad, Imani Jackson
Jul 25, 2007·The Journal of Sexual Medicine·David Rowland, Mark Burek
Jul 27, 2007·The Journal of Sexual Medicine·Paolo Maria MichettiChiara Simonelli
Sep 25, 2007·The Journal of Sexual Medicine·Amie FrewenKaterina Lagios
Sep 25, 2007·The Journal of Sexual Medicine·Vikas DhikavKuljeet Singh Anand
Nov 1, 2007·The Journal of Sexual Medicine·Alan ShindelSteven Brandes

❮ Previous
Next ❯

Citations

May 15, 2010·Current Urology Reports·Herbert J Wiser, Tobias S Köhler
Oct 16, 2012·Current Urology Reports·John Roger Bell, Eric Laborde
Jun 19, 2009·International Journal of Impotence Research·T A Skolarus, J T Wei
Jun 19, 2009·International Journal of Impotence Research·K KobayashiT Tsukamoto
Jul 15, 2011·Clinical Interventions in Aging·Masaki YoshidaKazuki Kawabe
Dec 1, 2010·Drug Design, Development and Therapy·Maxime Rossi, Thierry Roumeguère
Apr 3, 2014·Iranian Red Crescent Medical Journal·Yigit AkinBaris Nuhoglu
Aug 15, 2014·Current Urology Reports·Charles WelliverKevin T McVary
Jun 25, 2014·Autonomic Neuroscience : Basic & Clinical·L Camilo NavarreteJ Pablo Huidobro-Toro
May 20, 2015·Expert Opinion on Investigational Drugs·Kanika GuptaJeanny B Aragon-Ching
Jan 15, 2010·The Annals of Pharmacotherapy·Matthew A CantrellJames S Magera
Apr 3, 2012·Korean journal of urology·Tag Keun Yoo, Hee Ju Cho
Sep 12, 2015·PloS One·Masuomi TomitaAkira Shimada
Feb 25, 2009·Expert Opinion on Therapeutic Targets·Ibrahim A Abdel-HamidKarl-Erik Andersson
Dec 23, 2011·International Journal of Urology : Official Journal of the Japanese Urological Association·Yoshikazu SatoIchiya Honma
Jun 20, 2017·International Journal of Urology : Official Journal of the Japanese Urological Association·Yoshikazu SatoIchiya Honma
Oct 25, 2017·Journal of Assisted Reproduction and Genetics·Elizabeth R RayburnHaibo Li
Oct 6, 2017·Human Reproduction Update·Hagai LevineShanna H Swan
Mar 22, 2014·International Journal of Urology : Official Journal of the Japanese Urological Association·Yoshikazu Sato
Aug 26, 2010·International Journal of Urology : Official Journal of the Japanese Urological Association·Hideshi MiyakitaShuichi Yanada
Nov 22, 2017·The Cochrane Database of Systematic Reviews·Jae Hung JungPhilipp Dahm
Dec 14, 2018·Advances in Therapy·Luca VillaFrancesco Montorsi
May 2, 2017·The World Journal of Men's Health·Paolo CapogrossoAndrea Salonia

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.